Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/9492
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | MonoFIX-VF, a new mono-component factor IX concentrate: a single-centre continuous-infusion study |
Author: | Evans, G. Collett, M. Came, N. Lloyd, J. Powell, L. Street, A. |
Citation: | Haemophilia, 2002; 8(5):635-638 |
Publisher: | Blackwell Science Ltd |
Issue Date: | 2002 |
ISSN: | 1351-8216 1365-2516 |
Abstract: | <jats:p><jats:bold>Summary. </jats:bold> MonoFIX‐VF, a monocomponent factor IX concentrate, has replaced the use of Prothrombinex‐HT as the treatment of choice for patients with factor IX deficiency in Australia. The haemostatic effect of MonoFIX‐VF, administered by continuous infusion, was assessed in four subjects being treated for 10 bleeding episodes including five surgical procedures. MonoFIX‐VF was found to be a safe and effective treatment for patients with haemophilia B.</jats:p> |
DOI: | 10.1046/j.1365-2516.2002.00663.x |
Published version: | http://dx.doi.org/10.1046/j.1365-2516.2002.00663.x |
Appears in Collections: | Aurora harvest 4 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.